「japan」の検索結果
77件：46～50件目を表示
-
maged, leading to progressive visual field loss, and if left untreated, can result in blindness. In Japan, glaucoma is reported to be the leading cause of visual impairment (including reduced vision a...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf -
f Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that it has entered into...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307.pdf -
ion of Marketing Approval for “ Mytear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketin...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
Distribution of Software for Dry-eye Analysis Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distributi...
https://www.senju.co.jp/system/files/content_news/2024-09/ENG_20240906.pdf -
al Co., Ltd. Launch of Distribution of RET-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distributi...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726_0.pdf